Rochester’s Allison Lopatkin Named 2024 Pew Scholar in Biomedical Sciences

Lopatkin is one of 22 early-career scientists selected nationwide to explore some of the most pressing questions in human health and medicine.

Assistant Professor Allison Lopatkin is one of 22 scientists selected to join the Pew Scholars Program in the Biomedical Sciences this year. Her lab will explore the growing problem of antibiotic-resistant bacteria. (Credit: University of Rochester photo / Matt Wittmeyer).

Allison Lopatkin, PhD, an Assistant Professor of Chemical EngineeringBiomedical Engineering, and Microbiology and Immunology at the University of Rochester, Is one of 22 scientists selected to join the Pew Scholars Program in the Biomedical Sciences this year. The program provides early-career scientists four years of funding to explore some of the most pressing questions in human health and medicine. The funding will help Lopatkin’s lab explore how changes in bacterial metabolism contribute to the development of antibiotic resistance. She says that decades of antibiotic overuse—in both clinical and agricultural settings—have led to an alarming rise in bacterial strains that are resistant to antibiotics, contributing to a major public health concern.

Login Or Register To Read Full Story